“Cytodyn's Leronlimab and 100+ diseases.” Ohm
Post# of 145750
![Avatar](/images/ProfileImages/573000060_60093_FD245EF6-37BD-4C88-9356-29519D0376AD.jpeg)
“This is growing exponentially.” Cdiddy
“nice post and big!” - crazyjogger925
CYDY is struggling to finish the BLA, can’t fund the start of the mono trial, and had to conduct a different NASH preclinical study because apparently the first one wasn’t the industry standard. But by all means, let’s look into 100+ more diseases so we can hear about how great the preclinical results are and how it could result in licensing deal worth $1 billion (still waiting on that NASH deal).
No thanks.
Let’s get combo approved, start the mono trial, fill the two cancer trials and get some stinking funds in. Still no non-dilutive deal so the cash is burning, even more so with NP throwing $20K at Red Chip dumpster fires. Seriously though, how many GvHD or MS patients could CYDY have injected with the cash NP has wasted on videos and other advertising that only current investors watch?
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)